全文获取类型
收费全文 | 30304篇 |
免费 | 1773篇 |
国内免费 | 183篇 |
专业分类
耳鼻咽喉 | 426篇 |
儿科学 | 631篇 |
妇产科学 | 639篇 |
基础医学 | 3949篇 |
口腔科学 | 934篇 |
临床医学 | 2429篇 |
内科学 | 7892篇 |
皮肤病学 | 615篇 |
神经病学 | 2856篇 |
特种医学 | 1135篇 |
外国民族医学 | 2篇 |
外科学 | 4622篇 |
综合类 | 142篇 |
一般理论 | 10篇 |
预防医学 | 1563篇 |
眼科学 | 402篇 |
药学 | 1874篇 |
1篇 | |
中国医学 | 45篇 |
肿瘤学 | 2093篇 |
出版年
2023年 | 164篇 |
2022年 | 378篇 |
2021年 | 771篇 |
2020年 | 445篇 |
2019年 | 634篇 |
2018年 | 748篇 |
2017年 | 553篇 |
2016年 | 697篇 |
2015年 | 738篇 |
2014年 | 1070篇 |
2013年 | 1393篇 |
2012年 | 2114篇 |
2011年 | 2149篇 |
2010年 | 1225篇 |
2009年 | 1120篇 |
2008年 | 1936篇 |
2007年 | 1902篇 |
2006年 | 1802篇 |
2005年 | 1753篇 |
2004年 | 1649篇 |
2003年 | 1559篇 |
2002年 | 1416篇 |
2001年 | 391篇 |
2000年 | 418篇 |
1999年 | 385篇 |
1998年 | 264篇 |
1997年 | 250篇 |
1996年 | 231篇 |
1995年 | 211篇 |
1994年 | 180篇 |
1993年 | 165篇 |
1992年 | 221篇 |
1991年 | 182篇 |
1990年 | 188篇 |
1989年 | 176篇 |
1988年 | 194篇 |
1987年 | 212篇 |
1986年 | 176篇 |
1985年 | 175篇 |
1984年 | 159篇 |
1983年 | 138篇 |
1982年 | 109篇 |
1981年 | 105篇 |
1980年 | 86篇 |
1979年 | 105篇 |
1978年 | 101篇 |
1977年 | 68篇 |
1976年 | 67篇 |
1974年 | 72篇 |
1973年 | 82篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Mario Sénéchal Isabelle Lemieux Isabel Beucler Gerard Drobinski Sylvie Cormont Michelle Dubois Iradj Gandjbakhch Jean-Pierre Després Richard Dorent 《The Journal of heart and lung transplantation》2005,24(7):819-826
BACKGROUND: This study evaluated the prevalence of the atherogenic metabolic triad and the hypothesis that waist circumference and fasting triglyceride concentrations could be used as screening tools for identification of the atherogenic metabolic triad in a population of heart transplant men. It also evaluated the relationship between the atherogenic metabolic triad and coronary artery disease (CAD). METHODS: In the study group of 83 consecutive male heart transplant patients having their routine annual coronarography, 23 patients (28%) were characterized by the atherogenic metabolic triad defined by the presence of elevated fasting insulin and apolipoprotein B concentrations and by small low-density lipoprotein (LDL) particles. RESULTS: Seventy-seven per cent of patients with waist circumference values >/= 90 cm and with elevated triglyceride levels (>/=2.0 mmol/liter) were characterized by this atherogenic metabolic triad. Patients with the atherogenic metabolic triad were at markedly increased risk of CAD (odds ratio of 25.3, 95% CI: 1.11-577.3, p < 0.04) compared to heart transplant patients without the atherogenic metabolic triad. CONCLUSIONS: About 30% of heart transplant patients showed the features of the atherogenic metabolic triad. Measurement and interpretation of waist circumference and fasting triglycerides could be used among heart transplant patients to early identify men characterized by the presence of elevated fasting insulin and apolipoprotein B concentrations and small LDL particles. The presence of the atherogenic metabolic triad identified patients at high risk of CAD even in the heart transplant population. 相似文献
44.
Giuseppe Derosa Arrigo F G Cicero Angela D'Angelo Pietro D Ragonesi Leonardina Ciccarelli Mario N Piccinni Fabio Pricolo Sibilla A T Salvadeo Ilaria Ferrari Alessia Gravina Roberto Fogari 《Hypertension research》2006,29(11):849-856
The aim of our study was to investigate the metabolic effect of telmisartan and irbesartan in subjects treated with rosiglitazone, a well-known insulin-sensitizing drug, in order to clarify the direct metabolic effects of the two former drugs. Patients were enrolled, evaluated, and followed at 3 Italian centers. We evaluated 188 type 2 diabetic patients with metabolic syndrome (94 males and 94 females in total; 49 males and 46 females, aged 56+/-5, treated with telmisartan; and 45 males and 48 females, aged 55+/-4, treated with irbesartan). All had been diabetic for at least 6 months, and glycemic control by the maximum tolerated dietary changes and maximum tolerated dose of oral hypoglycemic agents had been attempted and failed in all cases. All patients took a fixed dose of rosiglitazone, 4 mg/day. We administered telmisartan (40 mg/day) or irbesartan (150 mg/day) in a randomized, controlled, double-blind clinical manner. We evaluated body mass index (BMI), glycemic control (HbA1c fasting plasma glucose and insulin levels [FPG, and FPI, respectively], and homeostasis model assessment [HOMA] index), lipid profile (total cholesterol [TC], low density lipoprotein-cholesterol [LDL-C], high density lipoprotein-cholesterol [HDL-C], and triglycerides [TG]), systolic and diastolic blood pressure (SBP and DBP), tumor necrosis factor-alpha (TNF-alpha), and leptin during the 12 months of this treatment. No BMI change was observed after 6 or 12 months in either group. Significant decreases in HbAlc and FPG were observed after 6 months in the telmisartan group, and after 12 months in both groups. The decrease in HbA1c and FPG at 12 months was statistically significant only in the telmisartan group. A significant decrease in FPI was observed at 12 months in both groups, and this decrease was significantly greater in the telmisartan group. Significant decreases in the HOMA index were observed at 6 and 12 months in both groups, and the decrease in the HOMA index after 12 months was significantly greater in the telmisartan group than in the irbesartan group. Significant changes in SBP, DBP, TC, and LDL-C were observed after 6 and 12 months in both groups. Significant decreases in TNF-alpha and leptin levels were observed after 6 months in the telmisartan group, and after 12 months in both groups. In conclusion, in this study of patients with type 2 diabetes mellitus and metabolic syndrome, telmisartan seemed to result in a greater improvement in glycemic and lipid control and metabolic parameters related to metabolic syndrome compared to irbesartan. These observed metabolic effects of different angiotensin type 1 receptor blockers could be relevant when choosing a therapy to correct metabolic derangement of patients affected by metabolic syndrome and diabetes. 相似文献
45.
46.
47.
Mario Kaufmann 《MedR Medizinrecht》2003,21(2):82-88
Ohne Zusammenfassung
Rechtsreferendar Mario Kaufmann, Wiss. Hilfskraft am Lehrstuhl für V?lkerrecht, Europarecht, Europ?isches und Internationales Wirtschaftsrecht (Prof. Dr.
Stephan Hobe) an der Universit?t zu K?ln, Neusser Stra?e 285, D-50733 K?ln 相似文献
48.
Francis J Podbielski Heron E Rodriguez Andrew M Brown Matthew J Blecha Mario R Salazar Mark M Connolly 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2004,8(3):213-216
Management of an indeterminate pulmonary nodule is a diagnostic challenge that commonly confronts primary care physicians and specialists. Patients often present with this radiographic finding in the course of an unrelated medical evaluation. We examined our institution's experience with percutaneous biopsy of lung nodules to determine the impact of this procedure on overall patient care. Although significant complications are uncommon, the expedience of percutaneous lung biopsy often supplants a surgical opinion prior to initiation of therapy without added diagnostic benefit or cost-savings. Hence, we caution practitioners to use this technique as an adjunct to diagnosis and not a substitute for multidisciplinary care. 相似文献
49.
50.
We report on a man without any symptoms until the age of 29 years when a ventricular tachyarrhythmia occurred for the first time. There were electrocardiographic signs of a previous myocardial infarction of the anterior wall, but there had not even been any episode of angina pectoris. The cause was the anomalous origin of the left coronary artery from the pulmonary trunk (Bland-White-Garland syndrome). Therapy consisted of ligation of the left coronary artery and the implantation of an aortocoronary vein graft to the left coronary artery in order to reinstall a two-coronary system. Diagnosis is easily made by coronary angiography. At a 3-year follow-up there was an increase of the ejection fraction/cardiac output, a stable sinus rhythm, and an improved physical endurance. 相似文献